Garth J. S. Cooper
Level 4
School of Biological Sciences
Faculty of Science
University of Auckland
Name/email consistency: high
- A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Cooper, G.J., Young, A.A., Gamble, G.D., Occleshaw, C.J., Dissanayake, A.M., Cowan, B.R., Brunton, D.H., Baker, J.R., Phillips, A.R., Frampton, C.M., Poppitt, S.D., Doughty, R.N. Diabetologia (2009)
- Fates intertwined. Cooper, G.J. Nat. Biotechnol. (2006)
- Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Cooper, G.J., Chan, Y.K., Dissanayake, A.M., Leahy, F.E., Keogh, G.F., Frampton, C.M., Gamble, G.D., Brunton, D.H., Baker, J.R., Poppitt, S.D. Diabetes (2005)
- Regeneration of the heart in diabetes by selective copper chelation. Cooper, G.J., Phillips, A.R., Choong, S.Y., Leonard, B.L., Crossman, D.J., Brunton, D.H., Saafi, L., Dissanayake, A.M., Cowan, B.R., Young, A.A., Occleshaw, C.J., Chan, Y.K., Leahy, F.E., Keogh, G.F., Gamble, G.D., Allen, G.R., Pope, A.J., Boyd, P.D., Poppitt, S.D., Borg, T.K., Doughty, R.N., Baker, J.R. Diabetes (2004)
